Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05657990

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Conditions: Urinary Retention

Sex: Male
Ages: 55 Years – N/A
Phase: EARLY_PHASE1
Enrollment: 46
Sponsor: Hackensack Meridian Health

Location: United States

Summary

This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.

Eligibility Criteria

Inclusion Criteria:Males≥55 years oldPlanned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.Surgery scheduled more than 7 days from the time of consentExclusion Criteria:Using Tamsulosin alreadyKnown allergy to Tamsulosin or sulfa drugsCurrent use of BoceprevirResting systolic blood pressure <100Orthostatic hypotension of >20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consentKnown history of hypotensionKnown diagnosis of congestive heart failure (CHF) and valvular heart diseaseHistory of prior prostate surgery (prostatectomy, trans-urethral resection)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05657990). StuddyBuddy aggregates publicly available trial information.